drugset / Trial / NCT05488860

Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases

NCT05488860

RandomizedParallel-groupSingle-blindTreatment

Summary

Piezoelectric drived microneedling treats refractory skin disorders using hollow microneedles assisted by ultrasound. Mechanically, the injection of medicine by hollow microneedling could makes the distribution of medicine more evenly. And the addition of ultrasound technique improves the effectiveness of microneedling. Investigators plan to conduct a pilot study to investigate the efficacy of using piezoelectric drived microneedles in treating refractory skin diseases.

Timeline

Start
2022-07-30
Primary completion
2024-06-30
Completion
2024-07-31

Drugs

EvaluationDrugModalityDoseRoute
Background Aminolevulinic Acid Diagnostic / imaging agent Other
Comparator Triamcinolone Acetonide Other / unclassified Other

Indications